Modi Naturals Ltd

Modi Naturals Limited trading window closed from Thursday, 1st October, 2026 till 48 hours after the publication of Un-Audited financial results of the Company for the quarter and half-year ended September 30th, 2026.

Meeting Details

• Date and time: 29 September 2026, 11:00–12:00.
• Nature of meeting: Investor Conference.
• Organised by: Arihant Capital Conference.
• Mode: Virtual.

Participants

• Key participants: company officials (management) to attend.

Purpose

• Discussions will be based on publicly available information; UPSI not intended.

Monthly report: Special Window transfers (Aug 2026)

• Period covered: 01-08-2026 to 31-08-2026 under SEBI Special Window.
• No transfer requests received for the period.
• No requests processed, approved, or rejected.
• Average processing time: 0 days.
• Registrar and Transfer Agent: Skyline Financial Services Private Limited.
• Report date: 07 September 2026.

Key disclosures

• MBPL received additional allocation of 1.98 crore litres of ethanol for EBPP ESY 2025-26.
• Estimated order value for the added allocation is ₹140 crores, with supplies through October 2026.
• Existing order stands at around ₹400 crores for ~47.9k KL from various OMCs.

Business Overview

• Modi Naturals operates edible oils, consumer foods, and a grain-based ethanol distillery expanding to 282 KLPD.
• Strategic focus on premium Oleev-branded oils, lean inventory, and ethanol-driven growth; Phase II commenced.

Operational Highlights

• Q1FY27 consolidated revenue ₹155.6 crore; EBITDA ₹22.2 crore; PAT ₹12.5 crore.
• Ethanol division secured additional ₹140 crore orders for ESY through Oct 2026; full capacity by Aug 2026.
• Phase I: 130 KLPD capex ₹125 cr; Phase II: 180 KLPD capex ₹100 cr; total 282 KLPD.
• Lean inventory model improved procurement discipline and working capital efficiency.
• EBITDA margin expanded to 14.2% in Q1FY27; PAT margin 8.0%.

Financial Performance

• Consolidated Q1FY27 revenue ₹155.6 crore; YoY growth 0.4%.
• EBITDA ₹22.2 crore; margin 14.2%; YoY EBITDA growth 25.6%.
• PAT ₹12.5 crore; margin 8.0%; YoY PAT growth 19.1%.
• FY26 consolidated revenue ₹719.2 crore; EBITDA ₹73.5 crore; PAT ₹50.3 crore.
• EBITDA margin FY26 10.2%; PAT margin 7.0%.

Capital Structure & Liquidity

• Borrowings reduced to ₹120.4 crore; Mar-25 borrowings ₹78.0 crore.
• Cash at end FY26: ₹1.8 crore; net cash from operations ₹61.1 crore.
• Total equity ₹172.1 crore; healthy liquidity headroom.

Strategic Priorities & Outlook

• FY27 guidance maintained; focus on disciplined growth, operational excellence, premiumisation, profitability.
• Phase II ethanol ramp-up; benefit from rising blending targets (E20 and beyond).
• Expanded distribution and product portfolio; new categories to offset oil seasonality.
• Lean working capital and cash generation to support growth.

Risks

• Regulatory and commodity-price risks; mitigated by inventory efficiency and diversified sourcing.
• Management confirms no major governance changes; existing leadership continuation.

Governance & Leadership

• Key management: Akshay Modi (JMD) and Anil Modi (Chairman); board includes independent directors.
• Brand strategy focuses Oleev, Karisma Kapoor campaign, and distribution expansion.

Approval of results

• Unaudited standalone and consolidated results for quarter ended 30 June 2026 approved; limited review reports attached.

Publication and filing

• Results to be published in newspapers and uploaded on the company website.

Auditor remarks

• Independent auditors' review reports indicate no material misstatement in results.

Segment information

• Standalone and consolidated segment data provided for Branded and Bulk for quarter ended 30 June 2026.

Board meeting details

• Board met on 14 August 2026; duration 2:00 PM to 6:45 PM.

Meeting Details

• Board meeting scheduled for Friday, 14 August 2026; time and venue not disclosed.

Key Agenda Items

• Consider and approve unaudited standalone and consolidated financial results for quarter ended 30 June 2026.

Other Notes

• Trading window closed until 48 hours after declaration of the results.

Special window transfer/demat—July 2026

• Period 01-07-2026 to 31-07-2026; 1 received, 1 processed, 0 approved, 1 rejected, 12-day average.
• Registrar: Skyline Financial Services Private Limited; status report dated 04 April 2026.

Subsidiary director appointment

• Appointment of Ankita Singal as Non-Executive Independent Women Director of Modi Biotech Pvt Ltd, effective 30 July 2026.
• Subsidiary: Modi Biotech Private Limited is an unlisted material subsidiary of Modi Naturals.
• No related party relationships; director is not debarred by MCA/SEBI orders.
• Profile: B.Com (H) from Lady Sriram College; MBA; ~20 years experience in finance, marketing, and general management.
• Relationship with Modi Naturals' directors: not related; no MCA/SEBI debarment.